A Novel stability indicating RP-UPLC chromatographic method was developed for analysis of Nevirapine in pharmaceutical formulations. The developed RP-UPLC method is superior in technology to conventional RP-HPLC with respect to speed, resolution, solvent consumption and cost of analysis. Nevirapine was subjected to the stress conditions like acid, base, thermal, oxidative and photolytic degradation. Nevirapine was found to degrade significantly in acid and thermal degradation. In acid degradation relative retention time with 0.42 is found as unknown impurity. New impurity was identified, isolated using mass based auto purification system and characterized by 1 H NMR ( 1 D and 2 D) and HRMS experiments. Isolated impurity was showing molecular weight of 244.10, molecular formula C 12 H 12 N 4 O 2 and its name as 2-(3-Amino-4-methylpyridin-2-ylamino)nicotinic acid. The calibration graph was linear and the method showed less deviation in accuracy results. The test solution was found to be stable for 20 days when stored in the refrigerator between 2˚C to 8˚C. The developed RP-UPLC method was validated and meets the requirements delineated by the International Conference on Harmonization (ICH) guidelines. The intra-day and inter-day variation was less than 1%. The method was reproducible and selective for the estimation of Nevirapine. Because the method could effectively separate the drug from its degradation products, it can be employed as a stability-indicating method.
Introduction
Nevirapine is structurally a member of the dipyridodiazepinone chemical class of Nevirapine was licensed after three clinical trials found that the combination of Nevirapine, AZT (zidovudine, Retrovir) and ddI (didanosine, Videx) brought about greater decreases in viral load and increases in CD4 cell counts than AZT and ddI taken without Nevirapine in patients who had not taken antiretroviral therapy before. The triple combination also led to fewer cases of HIV disease progression [2] [3] .
Several studies have reported that triple regimens including Nevirapine are as effective as protease inhibitor-containing regimens [4] . Concerns about the potency of Nevirapine in people who begin treatment with high viral load have been dispelled by these studies. A recent study has also demonstrated that Nevirapine is a safe and effective option for patients beginning therapy with a CD4 cell count below 200 cells/mm 3 
.
Treatment with Nevirapine mono-therapy is notorious for rapidly eliciting resistance due to mutations of the amino acids surrounding the NNRTI binding site [5] - [8] .
Few analytical methods are available in the literature for the determination of Nevirapine and other antiviral drugs in plasma. Few LC-MS methods are also available in literature to quantify the Nevirapine along with other retroviral drugs [9] - [15] . However, nowhere in the literature described shortest stability indicating UPLC method for analysis of Nevirapine.
It is important to study the all possible forced degradation pathways and degradation products for the drug Nevirapine, as new formulations and new manufacturing processes are developing day to date. Hence performed all degradation studies for the drug and thorough literature survey indicated that there is no data available on the characterization of acid degradation product of Nevirapine in literature. The present research work describes the stability indicating UPLC analysis of Nevirapine, identification, isolation and characterization of unknown degradation product formed in the acid degradation study. Developed method can be used to quantify the drug in formu- 
Equipment

Ultra Performance Liquid Chromatography
The Liquid chromatography system used for the method development and method validation consists of quaternary gradient pumps with auto sampler and auto injector connected with photo diode array detector controlled with Empower software. Eclipse plus C18 (50 × 4.6 1.8 µ) column was used from Agilent.
UPLC Chromatographic Conditions for Analysis of Nevirapine
Based on all the method development trials the below chromatographic conditions were finalized for analysis of Nevirapine, separation of degradation products from drug and for method validation. Optimized chromatographic conditions were shown in Table 1.
Mass Mediated Auto Purification Preparative HPLC
Waters Mass mediated purification system was used to purify the degradation products.
Mass mediated preparative HPLC equipped with waters pump module 2545, UV detector module 2996, mass detector module 3100, sample manager module 2767 and Mass lynx data handling system was used. 0.1% Formic acid was used as makeup solution for purification. Finalized preparative chromatographic conditions were shown in below 
FT-IR
The IR spectra was recorded in the solid state as KBr dispersion medium using Shimadzu IR Affinity-1 FT IR spectrophotometer. 
Sample Preparation
Preparation of Sample Solutions
Ten tablets were weighed to determine the average tablet weight and powdered in a 
Generation of Stress Samples
Specificity is the ability of the method to measure the analyte response in the presence of its potential impurities. As per ICH stability guidelines, different kinds of stress conditions i. e. heat, acidic, basic, oxidation and photolytic were employed [16] [17] . The details of the stress conditions applied were shown in Table 3 .
Preparation of Degradation Samples for Purification
Degradation was observed in thermal and acidic conditions. Directly 200 mg of Nevirapine kept in micro oven at 110˚C for 24 h and degraded sample was dissolved in 
Results and Discussion
Method Development of Chromatographic Conditions for Analysis of Nevirapine and Isolation of Degradation Products
The main object of this work was to develop new stability indicating analytical method for analysis of Nevirapine and isolation, characterization of unknown degradation product. Forced degradation studies were carried out to identify the degradation products and prove the stability indicating nature of reverse chromatographic method. To achieve the objectives of the method, development was carried out as follows.
To get separation of Nevirapine from its degradation products different chromatographic methods were tried using different stationary phases like C18, C8. Initial experiment was started with waters Symmetry C18 (75 × 4.6 3.5 µ) column, but Nevirapine related compound-A was not separating from drug peak and shape of the peak also not good. System suitability parameters were not passed with using waters Acquity BEH C18 (50 × 2.1 1.7 µ) column. Further method development was carried using waters X-Bridge column, Acquity BEH C8 and Agilent Eclipse C18 column. From the all trials it has been observed that Eclipse plus C18 (50 × 4.6 1.8 µ) seems to be better eluting all peaks with good separation and peak shape. 
Identification of Degradation Products of Nevirapine
Degradation was not found in base hydrolysis, Oxidative degradation and photolytic conditions which confirms that Nevirapine was found to be stable to base, oxidative degradation and photolytic conditions. The drug was found to be liable to acid hydrolysis as a total of 20.91% degradation was found (2 N HCl at 80˚C, up to 8 h) with a maximum individual degradation product of 14.48%. The drug degradation was also found in thermal degradation of 16.48% (at 110˚C, up 24 h) with a maximum individual degradation product of 9.98%. The method was specific because degradation products were separated to base line from main component and the peak purity flag passes for drug and degradation products which confirms the method is selective and homogeneity of the drug product. Degradation results of Nevirapine were shown in Table 4 .
Thermal and acid degradation chromatograms were shown in Figure 3 and Figure 4 . 
Isolation of Degradation Products of Nevirapine
As degradation was observed in acid and thermal stress condition, we intended to isolate degradation products of Nevirapine. For purification of degradation products several chromatographic conditions were tried to get good peak shape, recovery and loadabuility. Finally desired separation was achieved using the 10 mM ammonium bicar- 
Structure Confirmation of Degradation Products
To get structural insight, the HRMS analysis was carried out on isolated degradation 
Structure Elucidation of Unknown Acid Degradation Product
The HRMS data of this degradation product showed exact mass of the protonated mo- From all the spectral data, the structure of the degradation product was characterized as 2-(3-Amino-4-methylpyridin-2-ylamino) nicotinic acid with molecular formula C 12 H 12 N 2 O 4 and molecular weight 244.10. All chemical shift values, HSQC and HMBC correlations were shown in Table 5 . HRMS Report and complete spectral data were shown in Figures 6-9 . Proposed mechanism for formation of acid degradation product was shown in Figure 10. 
Method Validation
The developed UPLC method was taken up for validation. The analytical method validation [18] was carried in accordance with ICH guidelines.
Assay
Prepared standard and sample solutions were injected into developed chromatographic conditions and % of assay was calculated and the % of assay was found to be 99.6%.
System Suitability Test
Standard solution of Nevirapine (15 µg•mL −1 ) injected into the developed UPLC method to know the system suitability results. The typical retention time of Nevirapine is 2.82 min, USP tailing 1.21 and USP Plate count is 85350. C spectrum of acid degradation product.
Precision
The repeatability was checked by repeatedly injecting (n = 6) standard solution of Nevirapine. Retention times and the area RSD values for Nevirapine were found to be within 2.0% confirming a suitable precision of the method. Precision results were shown in Table 6 .
Linearity
The linear regression equation is y = 5581x − 300 and the correlation coefficient Table 7 . Linearity curve was shown in Figure 11 .
Accuracy
Assay method was conducted to determine accuracy of the method. The study was carried out at 50%, 100% and 150% for three replicate injections of each concentration of the analyte followed by calculation of the assay and results were shown in Table 8 .
Limit of Quantification (LOQ) and Limit of Detection
In accordance with International Conference on Harmonization (ICH) recommendations, the approach based on the standard deviations (SD) of the response and the slope of the calibration plot was used for determinations of limit of detection and limit of quantification. LOD and LOQ of drug calculated using the following equations designated by International Conference on Harmonization (ICH) guidelines. ). The effect of different column, different analyst, and different system was also studied as part of the ruggedness of the method. System suitability Figure 11 . Linearity curve of Nevirapine. parameters like USP plate count, USP tailing were checked and they found to be within the limits.
Specificity
Forced degradation study of the drug substance can help to identify the stability of the molecule and possible degradation products and also validate the stability and specificity of the analytical procedures. Acid, base, thermal, oxidative and photolytic degradation sample solutions were injected into the developed method to know the specificity of the method. Degradation was observed in acidic, thermal conditions. Developed method was able to separate all degradation products from drug compound, so it can be employed as stability indicating method. Degradation was not observed in base, oxidative and photolytic conditions. Degradation results were shown in Table 9 .
Conclusion
The simple, fast and economic method was developed to analysis of Nevirapine. Forced degradation studies were performed to assess the stability of the compound and prove the stability indicating nature of the developed chromatographic method. All degradation products were isolated and two of them confirmed as reported impurities. In acid degradation study unknown impurity was observed and that impurity was isolated and confirmed the structure by using spectroscopic techniques like NMR, Mass and FT-IR. 
